Related references
Note: Only part of the references are listed.Silibinin is a direct inhibitor of STAT3
Sara Verdura et al.
FOOD AND CHEMICAL TOXICOLOGY (2018)
The Multifaceted Role of STAT3 in Mammary Gland Involution and Breast Cancer
Katherine Hughes et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Psoriasis: A STAT3-Centric View
Enzo Calautti et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
STAT3 Interactors as Potential Therapeutic Targets for Cancer Treatment
Federica Laudisi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis
Neibla Priego et al.
NATURE MEDICINE (2018)
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
Daniel E. Johnson et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Inhibition of STAT3 with the Generation 2.5 Antisense Oligonucleotide, AZD9150, Decreases Neuroblastoma Tumorigenicity and Increases Chemosensitivity
Seiichi Odate et al.
CLINICAL CANCER RESEARCH (2017)
STAT3 in cancer: A double edged sword
Lidia Avalle et al.
CYTOKINE (2017)
Genomic Evolution of Breast Cancer Metastasis and Relapse
Lucy R. Yates et al.
CANCER CELL (2017)
Constitutive activation of STAT3 in breast cancer cells: A review
Kasturi Banerjee et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the, bone marrow
Rachelle W. Johnson et al.
NATURE CELL BIOLOGY (2016)
Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
Jesse M. Zaretsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignancies
A. L. Wong et al.
ANNALS OF ONCOLOGY (2015)
Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis
Beatrice Grabner et al.
NATURE COMMUNICATIONS (2015)
Phase I Study of OPB-31121, an Oral STAT3 Inhibitor, in Patients with Advanced Solid Tumors
Do-Youn Oh et al.
CANCER RESEARCH AND TREATMENT (2015)
Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors
Kodappully Sivaraman Siveen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2014)
Leukemia cell-targeted STAT3 silencing and TLR9 triggering generate systemic antitumor immunity
Dewan Md Sakib Hossain et al.
BLOOD (2014)
STAT signaling in different breast cancer sub-types
Priscilla A. Furth
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
The Stat3 paradox: A killer and an oncogene
Henrike K. Resemann et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
p70S6 kinase mediates breast cancer cell survival in response to surgical wound fluid stimulation
Ilenia Segatto et al.
MOLECULAR ONCOLOGY (2014)
Surgery-induced wound response promotes stem-like and tumor-initiating features of breast cancer cells, via STAT3 signaling
Ilenia Segatto et al.
ONCOTARGET (2014)
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
Hua Yu et al.
NATURE REVIEWS CANCER (2014)
Mechanisms of disseminated cancer cell dormancy: an awakening field
Maria Soledad Sosa et al.
NATURE REVIEWS CANCER (2014)
Inhibition of breast cancer local relapse by targeting p70S6 kinase activity
Ilenia Segatto et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2013)
Dormancy Signatures and Metastasis in Estrogen Receptor Positive and Negative Breast Cancer
Ryung S. Kim et al.
PLOS ONE (2012)
Toll-like Receptor 4 Variant D299G Induces Features of Neoplastic Progression in Caco-2 Intestinal Cells and Is Associated With Advanced Human Colon Cancer
Annette Eyking et al.
GASTROENTEROLOGY (2011)
Stat3 Is Required for Anchorage-Independent Growth and Metastasis But Not for Mammary Tumor Development Downstream of the ErbB-2 Oncogene
Isaia Barbieri et al.
MOLECULAR CARCINOGENESIS (2010)
STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors
Heehyoung Lee et al.
NATURE MEDICINE (2010)
Identification of a Stat3-Dependent Transcription Regulatory Network Involved in Metastatic Progression
Jill J. Ranger et al.
CANCER RESEARCH (2009)
Elevated Biomarkers of Inflammation Are Associated With Reduced Survival Among Breast Cancer Patients
Brandon L. Pierce et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Stat3 and the Inflammation/Acute Phase Response in Involution and Breast Cancer
Sara Pensa et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2009)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
Tumor dormancy and surgery-driven interruption of dormancy in breast cancer: learning from failures
Romano Demicheli et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2007)
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment
Hua Yu et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Evaluation of potential Stat3-regulated genes in human breast cancer
FC Hsieh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
In vivo antitumor efficacy of STAT3 blockade using a transcription factor decoy approach:: implications for cancer therapy
SC Xi et al.
ONCOGENE (2005)
Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis
KS Chan et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Linking inflammation to cell cycle progression
G Baldassarre et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
STAT proteins as novel targets for cancer drug discovery
J Turkson
EXPERT OPINION ON THERAPEUTIC TARGETS (2004)
Does surgery modify growth kinetics of breast cancer micrometastases?
R Demicheli et al.
BRITISH JOURNAL OF CANCER (2001)
Tumour dormancy: findings and hypotheses from clinical research on breast cancer
R Demicheli
SEMINARS IN CANCER BIOLOGY (2001)
Signal transducers and activators of transcription as regulators of growth, apoptosis and breast development
J Bromberg
BREAST CANCER RESEARCH (2000)
Share Paper
